KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio: 2009-2019

Historic FCF Payout Ratio for Teva Pharmaceutical Industries (TEVA) over the last 11 years, with Dec 2019 value amounting to 0.23.

  • Teva Pharmaceutical Industries' FCF Payout Ratio rose 100.17% to 0.01 in Q1 2018 from the same period last year, while for Mar 2018 it was 0.21, marking a year-over-year decrease of 56.45%. This contributed to the annual value of 0.23 for FY2019, which is 3388.04% up from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its FCF Payout Ratio stood at 0.23 for FY2019, which was up 3,388.04% from 0.01 recorded in FY2018.
  • Teva Pharmaceutical Industries' FCF Payout Ratio's 5-year high stood at 0.67 during FY2017, with a 5-year trough of 0.01 in FY2018.
  • Over the past 3 years, Teva Pharmaceutical Industries' median FCF Payout Ratio value was 0.23 (recorded in 2019), while the average stood at 0.30.
  • Its FCF Payout Ratio has fluctuated over the past 5 years, first crashed by 99.00% in 2018, then soared by 3,388.04% in 2019.
  • Teva Pharmaceutical Industries' FCF Payout Ratio (Yearly) stood at 0.24 in 2015, then soared by 80.03% to 0.44 in 2016, then skyrocketed by 52.99% to 0.67 in 2017, then crashed by 99.00% to 0.01 in 2018, then soared by 3,388.04% to 0.23 in 2019.